House Republicans have blocked a bill that would allow dentures to be repaired at pharmacies after a recent federal investigation.
The House Committee on Health and Human Services, which oversees the Food and Drug Administration, rejected a bill by Rep. Andy Biggs (R-Ariz.) on Wednesday that would have allowed dental implants to be returned to consumers after being repaired.
The move came a day after the FDA issued a notice of proposed rulemaking, or PMR, regarding the reinstatement of dental implants.
Biggs, who represents a district that includes parts of Arizona, Arizona’s second-largest city, had previously proposed legislation that would give consumers more time to receive their implants, which are made by OrthoHealth, a San Francisco-based dental health company.
The bill would have required that a consumer who returned a dental implant be notified within seven days of receiving the implant.
But Biggs’ bill, which would have applied to dental implants made between May 1, 2021, and January 31, 2022, has been stalled.
The FDA’s latest notice of proposal is a move by the agency to address concerns about the safety of implants that have been linked to the coronavirus outbreak.
The agency also said the current PMR process for implant replacement is insufficient to protect the public from dental injuries.
“Consumers who want to return a dental implants should have an opportunity to do so in a timely manner.
This should not be the case for dental implants that were not originally repaired,” the FDA said in a statement.
Bigg’s bill would allow the consumer to notify Orthohealth within seven business days if a dental appliance has not been repaired in five years.
The legislation, however, would not apply to implants made prior to 2021.
“The bill is an effort to protect our consumers from the catastrophic consequences of a coronaviruses coronaviral coronaviolosis,” said Representative Steve Palazzo (R.I.), who introduced the bill.
“It is unfortunate that this misguided legislation was not acted upon.
If the FDA is not willing to act now to protect consumers, then we should not expect that they will act in the future.”
OrthoHaus is the parent company of the orthodontic implant maker Ortho Health Corp., which manufactures and sells implants.
In December, the FDA announced it would not approve Ortho health’s implant replacement product after it was linked to more than 50 deaths.
The company had previously announced it was reducing its global sales by 60 percent by the end of the year.